Autoantibodies and Clinical Symptoms in Infective Endocarditis Patients

NCT00562653 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2007-11-22

No results posted yet for this study

Summary

The purpose is to evaluate autoantibodies in infective endocarditis patients before, at the beginning of treatment, and after the end of the treatment, and to correlate the autoantibodies in the presence of clinical symptoms.

Conditions

  • Infective Endocarditis

Sponsors & Collaborators

  • Ministry of Health, Israel

    collaborator OTHER_GOV
  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Principal Investigators

  • Victoria Bogusllavsky, MD · Sourasky Medical Center, Internal Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Completion
2008-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00562653 on ClinicalTrials.gov